Logo-npj

J Nephropharmacol. 2022;11(2): e10458. doi: 10.34172/npj.2022.10458

Review

Ameliorative effects of pirfenidone in chronic kidney disease

Samad Ghodrati 1,2 ORCID, Yeganeh Ragati Haghi 3 ORCID, Jyoti Baharani 4 ORCID, Akshaya Joseph 5 ORCID, Niloufar Alimohammadi 6 ORCID, Farzad Koosha 7 ORCID, Leila Mostafavi 8 ORCID, Aiyoub Pezeshgi 1,2 * ORCID

Cited by CrossRef: 1

1- Ghelichi-Ghojogh M, fararouei M, Seif M, Pakfetrat M. Environmental factors and chronic kidney disease: a case-control study. Sci Rep. 2024;14(1) [Crossref]
2- Raad kareem Alwan A, Oraibi A, Al-Saady T, Almukram A, Halool Mohammed S, Hamza AlShammari A, Saleem M, Said M, Dauelbait M, Zohaib H, Almohammed O. Therapeutic Potential of Pirfenidone in Adenine-Induced Chronic Kidney Disease: An Integrated Experimental and In Silico Study. Appl Biochem Biotechnol. 2026; [Crossref]